In my opinion, it won't. The phenomenon was studied between 1998 and 2004. It took a long time. The regulations established are really strict, especially compared to the regulations in other countries.
That isn't the issue. The issue is how far the process will go, because there's a limit. When this limit is exceeded, there are never any issues with the products, which are safe. The debate isn't about determining whether the products are safe. The debate is about determining where the limit lies. Will more and more regulations be imposed? That's what we're seeing. Sometimes, we see this in the interpretation of the regulations.
Even now, as we debate the regulations, that isn't the issue. It goes beyond that. It's ongoing. Whether it's labelling, Vanessa's Law or cost recovery, everything has been established for drugs. People didn't take the time to truly understand these products. Now they're playing catch‑up. More consultations are being held now. However, when everything that we've been discussing was established, the necessary consultations weren't held. That's why we're here.